For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251006:nRSF1647Ca&default-theme=true
RNS Number : 1647C Brave Bison Group PLC 06 October 2025
6 October 2025
Brave Bison Group plc
("Brave Bison" or the "Company", together with its subsidiaries "the Group")
Notice of General Meeting & Posting of Circular
Board recommends voting against proposed resolution
Brave Bison, the next-generation marketing and technology partner for global
brands, is today posting a circular (the "Circular") to the Company's
shareholders convening a general meeting in response to a requisition notice
received on 25 September 2025 on behalf of Lord Michael Ashcroft (the
"Requisitioning Member"). The requisitioned general meeting will be held at
9.00 am on 24 October 2025 at 2 Stephen Street, London, W1T 1AN (the
"Requisitioned General Meeting").
The purpose of the Requisitioned General Meeting will be to consider a
resolution to appoint Julia Robertson, a nominated director on behalf of the
Requisitioning Member, to the Company's Board as a non-executive director (the
"Resolution"). The Resolution will be proposed to the Requisitioned General
Meeting as an ordinary resolution requiring 50% of votes cast to pass.
The Board, having consulted with shareholders and the Company's strategic
partners News Corp. and Professor Mark Ritson, has unanimously determined that
the Resolution is not in the best interests of the Company. Written
indications of support for the Board's position in this regard have been
received from shareholders representing 51% of the Company's issued share
capital who intend to vote against the Resolution.
The Board recommends that shareholders vote against the proposed resolution at
the Requisitioned General Meeting.
A copy of the Circular, including the full text of the explanatory statement
accompanying the requisition and a letter from the Chairman of Brave Bison as
set out below, will shortly be available from the Company's website at
www.bravebison.com.
Enquiries:
Brave Bison Group plc
Oliver Green, Chairman
via
Cavendish
Theo Green, Chief Growth Officer
Philippa Norridge, Chief Financial Officer
Cavendish Capital
Markets
Tel: +44 (0) 20 7220 0500
Nominated Adviser & Broker
Ben Jeynes / Teddy Whiley / Elysia Bough - Corporate Finance
Michael Johnson / Sunila de Silva - ECM
--------------------------------------
Letter from the Chairman of Brave Bison Group plc to Shareholders
Dear Shareholder,
We are today convening a general meeting to consider the appointment of a new
director, nominated by the Requisitioning Member, to the Board of Brave Bison.
The Board, having consulted with shareholders and our strategic partners News
Corp. and Professor Mark Ritson, has unanimously determined that this
resolution is not in the best interests of the Company. Written indications of
support for the Board's position, and confirming intent to vote against the
resolution at the general meeting, have been received from shareholders
representing 51% of the Company's issued share capital.
The Board remains confident in the current strategic direction of Brave Bison
and will continue to evolve both corporate governance and Board composition in
line with the Company's growth and increasing scale.
I ask for your support in voting against the resolution set out above at the
forthcoming general meeting.
Oliver Green
Chairman
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOGFLFIAIALEIIE